ArticleCancer research communications2022

Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors.

Ana M Metelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.